Your browser doesn't support javascript.
loading
Photocatalytic Isomerization of (E)-Anethole to (Z)-Anethole.
Korff, Marvin; Paulisch, Tiffany O; Glorius, Frank; Doltsinis, Nikos L; Wünsch, Bernhard.
Afiliação
  • Korff M; Westfälische Wilhelms-Universität Münster, Chemical Biology of Ion Channels (Chembion), GRK 2515, Corrensstraße 48, D-48149 Münster, Germany.
  • Paulisch TO; Westfälische Wilhelms-Universität Münster, Institut für Pharmazeutische und Medizinische Chemie, Corrensstraße 48, D-48149 Münster, Germany.
  • Glorius F; Westfälische Wilhelms-Universität Münster, Chemical Biology of Ion Channels (Chembion), GRK 2515, Corrensstraße 48, D-48149 Münster, Germany.
  • Doltsinis NL; Westfälische Wilhelms-Universität Münster, Organisch-Chemisches Institut, Corrensstraße 40, D-48149 Münster, Germany.
  • Wünsch B; Westfälische Wilhelms-Universität Münster, Chemical Biology of Ion Channels (Chembion), GRK 2515, Corrensstraße 48, D-48149 Münster, Germany.
Molecules ; 27(16)2022 Aug 22.
Article em En | MEDLINE | ID: mdl-36014580
ABSTRACT
Natural product (E)-anethole was isomerized to (Z)-anethole in a photocatalytic reaction. For this purpose, a self-designed cheap photoreactor was constructed. Among 11 photosensitizers (organo and metal complex compounds), Ir(p-tBu-ppy)3 led to the highest conversion. Triplet energies of (E)- and (Z)-anethole were predicted theoretically by DFT calculations to support the selection of appropriate photosensitizers. A catalyst loading of 0.1 mol% gave up to 90% conversion in gram scale. Further additives were not required and mild irradiation with light of 400 nm overnight was sufficient. As a proof of concept, (E)- and (Z)-anethole were dihydroxylated diastereoselectively to obtain diastereomerically pure like- and unlike-configured diols, respectively.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Fotossensibilizantes / Derivados de Alilbenzenos Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Fotossensibilizantes / Derivados de Alilbenzenos Idioma: En Ano de publicação: 2022 Tipo de documento: Article